Sirtuins - novel therapeutic targets to treat age-associated diseases

被引：378

作者：

Lavu, Siva ^{[1
]}

Boss, Olivier ^{[1
]}

Elliott, Peter J. ^{[1
]}

Lambert, Philip D. ^{[1
]}

机构：

[1] Sirtris Pharmaceut GSK Co, Cambridge, MA 02139 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2008年 / 7卷 / 10期

关键词：

D O I：

10.1038/nrd2665

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Sirtuins post-translationally modulate the function of many cellular proteins that undergo reversible acetylation-deacetylation cycles, affecting physiological responses that have implications for treating diseases of ageing. Potent small-molecule modulators of sirtuins have shown efficacy in preclinical models of metabolic, neurodegenerative and inflammatory diseases, and so hold promise for drug discovery efforts in multiple therapeutic areas. Here, we discuss current knowledge and data that strengthens sirtuins as a druggable set of enzymes for the treatment of age-associated diseases, including activation of SIRT1 in type 2 diabetes.

引用

页码：841 / 853

页数：13

共 160 条

[11] SIRT1 transgenic mice show phenotypes resembling calorie restriction
Bordone, Laura
Cohen, Dena
Robinson, Ashley
Motta, Maria Carla
van Veen, Ed
Czopik, Agnieszka
Steele, Andrew D.
Crowe, Hayley
Marmor, Stephen
Luo, Jianyuan
Gu, Wei
Guarente, Leonard
[J]. AGING CELL, 2007, 6 (06) : 759 - 767
[12] Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on pituitary function in rats
Böttner, M
Christoffel, J
Jarry, H
Wuttke, W
[J]. JOURNAL OF ENDOCRINOLOGY, 2006, 189 (01) : 77 - 88
[13] Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β
Bowers, JL
Tyulmenkov, VV
Jernigan, SC
Klinge, CM
[J]. ENDOCRINOLOGY, 2000, 141 (10) : 3657 - 3667
[14] Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A
Sweeney, LB
Sturgill, JF
Chua, KF
Greer, PL
Lin, YX
Tran, H
Ross, SE
Mostoslavsky, R
Cohen, HY
Hu, LS
Cheng, HL
Jedrychowski, MP
Gygi, SP
Sinclair, DA
Alt, FW
Greenberg, ME
[J]. SCIENCE, 2004, 303 (5666) : 2011 - 2015
[15] How is mitochondrial biogenesis affected in mitochondrial disease?
Chabi, B
Adhihetty, PJ
Ljubicic, V
Hood, DA
[J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2005, 37 (12) : 2102 - 2110
[16] Increase in activity during calorie restriction requires Sirt1
Chen, D
Steele, AD
Lindquist, S
Guarente, L
[J]. SCIENCE, 2005, 310 (5754) : 1641 - 1641
[17] Histone H2A.z is essential for cardiac myocyte hypertrophy but opposed by silent information regulator 2α
Chen, Ieng-Yi
Lypowy, Jacqueline
Pain, Jayashree
Sayed, Danish
Grinberg, Stan
Alcendor, Ralph R.
Sadoshima, Junichi
Abdellatif, Maha
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (28) : 19369 - 19377
[18] SIRT1 protects against microglia-dependent amyloid-β toxicity through inhibiting NF-κB signaling
Chen, J
Zhou, YG
Mueller-Steiner, S
Chen, LF
Kwon, H
Yi, SL
Mucke, L
Li, G
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (48) : 40364 - 40374
[19] Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses
Chen, WY
Wang, DH
Yen, RWC
Luo, JY
Gu, W
Baylin, SB
[J]. CELL, 2005, 123 (03) : 437 - 448
[20] Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
Cheng, HL
Mostoslavsky, R
Saito, S
Manis, JP
Gu, YS
Patel, P
Bronson, R
Appella, E
Alt, FW
Chua, KF
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) : 10794 - 10799

← 1 2 3 4 5 6 7 8 9 10 →